Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

NewPath Probiotics

NewPath Probiotics provides a sinus probiotic.
2018
02-Oct
02-10
Chicago, Illinois, United States
  • Consumer Healthcare
  • Nutraceuticals (e.g. Supplements)
  • Probiotics

Innovation

Industry Problem

Recurring sinus congestion and microbiome disruption have few consumer probiotic products designed specifically for the nasal cavity.

R&D Focus

Nasal and sinus probiotics.

Innovative Solution

The company developed a nasal probiotic intended to introduce beneficial bacteria directly into the sinus environment.

Investment Funding

Last Funding Stage

Seed

Last Funding Date

17-08-2018

Startup Stage

Seed

Lead Investors

SOSV, RebelBio

Revenue

$1M to $10M

People

Founders

About

NewPath Probiotics provides a sinus probiotic.

Products

Product

NewPath sinus probiotic for nasal microbiome support.

Demo Product or Complete Product?

Early-stage product development and crowdfunding; current reliable sources describe the company as inactive.

Future Plan

Investment Funding

Received early seed support through the SOSV/RebelBio ecosystem and pursued an Indiegogo launch.

Awards and Recognitions

Participations

RebelBio Cohort VI.

Something missing or incorrect on this page? Help us enrich this information